| Shannon Dempsey, | |
|
14315 108th Ave Ste 230, Orland Park, IL 60467-5701 | |
| (708) 675-2100 | |
| Not Available |
| Full Name | Shannon Dempsey |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 14315 108th Ave Ste 230, Orland Park, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023681418 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146014360 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Dempsey, 15000 El Cameno Real Dr, Orland Park, IL 60462-3126 Ph: (708) 703-0904 | Shannon Dempsey, 14315 108th Ave Ste 230, Orland Park, IL 60467-5701 Ph: (708) 675-2100 |
News Archive
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in a Phase 3b study (PKU-016) to evaluate the effects of Kuvan (sapropterin dihydrochloride) on neuropsychiatric symptoms in subjects with phenylketonuria (PKU). BioMarin expects to report results in the first half of 2012.
Researchers from the University of Southern California and the Doheny Eye Institute will be presenting data on the first six patients implanted with an intraocular retinal prosthesis-more popularly referred to as an artificial retina-developed and manufactured in partnership with Second Sight Medical Products, of Sylmar, Calif.
The American Association of Nurse Practitioners, the largest professional membership organization for nurse practitioners in the world, today released survey results that show widespread, national support among the general public for legislative and policy proposals that give patients access to NP care and services.
A gut hormone that causes people to eat more does so by making food appear more desirable, suggests a new report in the May issue of Cell Metabolism, a publication of Cell Press. In a brain imaging study of individuals, the researchers found that reward centers respond more strongly to pictures of food in subjects who had received an infusion of the hormone known as ghrelin.
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that key data from its JX-594 intravenous administration Phase 1 dose escalation clinical study will be presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting taking place May 19-22, 2010, in Washington DC.
› Verified 9 days ago
Tawny Underwood, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11045 Karen Dr, Orland Park, IL 60467 Phone: 309-333-4169 | |
Lauren Cain, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14601 John Humphrey Dr, Orland Park, IL 60462 Phone: 708-349-8300 | |
Rebecca Sylve, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15709 Scotsglen Rd, Orland Park, IL 60462 Phone: 708-415-6950 | |
Ms. Maria R Metzler, M.A. CCC-SLP.L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18105 Waterside Cir, Orland Park, IL 60467 Phone: 708-305-0487 Fax: 866-881-0484 | |
Mrs. Janis Ann Petru, M.S., CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 60 Orland Square Dr, Suite 203, Orland Park, IL 60462 Phone: 708-364-7046 Fax: 708-364-7048 | |
Maryellen Serritella, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16170 S Kingsport Rd, Orland Park, IL 60467 Phone: 708-326-1550 |